Tempus AI Deepens Precision Oncology Role With New HRD And Lung Tools [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Tempus AI (NasdaqGS:TEM) has launched a new AI-driven HRD-RNA algorithm aimed at improving cancer diagnostics. The company has entered a partnership with Median Technologies to bring advanced lung cancer screening solutions onto its platform. The collaboration follows recent FDA clearance of Median's eyonis LCS tool for lung cancer screening. For investors watching the growth of AI in healthcare, Tempus AI sits at the intersection of data, diagnostics, and oncology. The new HRD-RNA algorithm and the integration of AI-based lung cancer screening tools fit within the broader move toward precision medicine, where treatment decisions increasingly depend on granular molecular and imaging data. These developments highlight how software and clinical workflows are becoming more closely linked in cancer care. Looking ahead, the key questions for NasdaqGS:TEM revolv
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (GH) Gained from Better-Than-Expected Results [Yahoo! Finance]Yahoo! Finance
- Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- Guardant Health acquires MetaSight amid positive 2026 financial outlook [Yahoo! Finance]Yahoo! Finance
- Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Guardant Health (NASDAQ:GH) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
GH
Earnings
- 2/19/26 - Beat
GH
Sec Filings
- 2/23/26 - Form 4
- 2/20/26 - Form S-8
- 2/19/26 - Form 10-K
- GH's page on the SEC website